tiprankstipranks
Trending News
More News >
Cytosorbents Corp (CTSO)
NASDAQ:CTSO
US Market

Cytosorbents (CTSO) Income Statement

Compare
485 Followers

Cytosorbents Income Statement

Last quarter (Q2 2025), Cytosorbents's total revenue was $9.62M, an increase of 8.76% from the same quarter last year. In Q2, Cytosorbents's net income was $1.95M. See Cytosorbents’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 35.59M$ 31.08M$ 34.69M$ 40.11M$ 39.45M
Gross Profit
$ 25.13M$ 21.95M$ 20.73M$ 29.06M$ 28.40M
Operating Expenses
$ 41.91M$ 53.90M$ 52.25M$ 51.81M$ 38.77M
Depreciation and Amortization
$ 1.57M$ 2.02M$ 882.62K$ 1.13M$ 660.79K
EBITDA
$ -15.22M$ -27.88M$ -30.00M$ -21.62M$ -9.71M
Operating Income
$ -16.79M$ -31.95M$ -31.52M$ -22.74M$ -10.37M
Other Income/Expenses
$ -5.62M$ 1.89M$ -2.38M$ -2.55M$ 1.41M
Pretax Income
$ -22.41M$ -30.06M$ -33.91M$ -25.29M$ -8.96M
Net Income
$ -20.72M$ -29.25M$ -32.81M$ -24.56M$ -7.84M
Per Share Metrics
Basic EPS
$ -0.38$ -0.65$ -0.75$ -0.57$ -0.20
Diluted EPS
$ -0.38$ -0.65$ -0.75$ -0.57$ -0.20
Weighted Average Shares Outstanding
54.43M 44.66M 43.57M 43.36M 38.82M
Weighted Average Shares Outstanding (Diluted)
54.43M 44.66M 43.57M 43.36M 38.82M
Currency in USD

Cytosorbents Earnings and Revenue History